Identification of a Novel Founder EYA4 Structural Variant in North America
Human Mutation · 2026-01 · 2026 (1)
DOI: 10.1155/humu/4463081 ↗Kurz gefasst
Fachartikel in der Zeitschrift Human Mutation, online erschienen am 02.07.2026. Verfasst von Jacquelyn K. DeVries und 7 weiteren Autor:innen. Die Arbeit nennt 33 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Institute on Deafness and Other Communication Disorders.
Abstract (Originalsprache)
Objective(s) Autosomal dominant nonsyndromic hearing loss (ADNSHL) is a genetically heterogeneous disorder. Copy‐number and structural variants (SVs) in EYA4 are a rare cause of hearing loss at the DFNA10 locus. We aimed to determine the genetic etiology of hearing loss in a series of families with ADNSHL.
Methods
We performed a retrospective review of patients referred for targeted genomic enrichment and massively parallel sequencing using the OtoSCOPE panel, which covers known genes associated with nonsyndromic hearing loss (NSHL). Genetic findings and available phenotypic data were reviewed by a multidisciplinary team to assess variant pathogenicity. Haplotypes were reconstructed using variants in EYA4 and flanking regions.
Results
A novel pathogenic SV in EYA4 involving a 5.8 kb deletion of the Terminal Exons 19 and 20, with insertion of a short, inverted downstream sequence, was identified in five North American probands with a family history consistent with ADNSHL. Segregation analysis demonstrated cosegregation with hearing loss in two affected relatives. This SV is the most frequently detected pathogenic variant in EYA4 in our cohort, accounting for five of 25 (20%) DFNA10 diagnoses to date. Haplotype reconstruction demonstrated an extended shared 857 kB haplotype surrounding the region.
Conclusion
This study expands the mutational spectrum of EYA4 ‐associated hearing loss. The complexity of this novel SV, its identical breakpoint structure, and shared haplotype support a founder origin of this allele rather than a recurrent event. These findings highlight the importance of systematic and comprehensive CNV/SV analysis in routine genetic testing for hearing loss and show that clinically relevant complex SVs may be overlooked without careful evaluation.
Förderung
- National Institute on Deafness and Other Communication Disorders
Zitieren
APA
DeVries, J. K., Klimara, M. J., Odell, A. M., Kolbe, D. L., Meyer, N., Harlan, P. L., Azaiez, H., & Smith, R. J. H. (2026). Identification of a Novel Founder EYA4 Structural Variant in North America. Human Mutation, 2026(1). https://doi.org/10.1155/humu/4463081
Vancouver
DeVries JK, Klimara MJ, Odell AM, Kolbe DL, Meyer N, Harlan PL, et al. Identification of a Novel Founder EYA4 Structural Variant in North America. Human Mutation. 2026;2026(1). doi:10.1155/humu/4463081
BibTeX
@article{DeVries2026,
author = {DeVries, Jacquelyn K. and Klimara, Miles J. and Odell, Amanda M. and Kolbe, Diana L. and Meyer, Nicole and Harlan, Paige L. and Azaiez, Hela and Smith, Richard J. H.},
title = {Identification of a Novel Founder EYA4 Structural Variant in North America},
journal = {Human Mutation},
year = {2026},
volume = {2026},
number = {1},
doi = {10.1155/humu/4463081}
}
EUVIMED